// App-Quantinova.ai

BIOM-56 : MIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATIONMIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATION

Researchers

Presenter

  • Clemens Oliver Hanemann

Principal Investigators

  • Ahmed Abdelrahman

  • Claire Adams

  • Felix Sahm

  • Tadeja Urbanic-Purkart

  • Michael Khalil

  • Raffaella Vergura

  • Cristina Morelli

Medical Centers

  • MTA, Lugano, Switzerland

  • Department of Neurology, Medical University of Graz, Graz, Austria

  • Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom

  • MTA, Ferrara, Italy

  • Department of Neuropathology, University Hospital Heidelberg, and Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Locations

  • Switzerland

  • Italy

  • Austria

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Meningiomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A